Assistant Director of Drug Development

Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced Cancers

CERo Therapeutics Progresses Phase 1 CER-1236 AML Trial with Dosing of Third Patient in Initial Dose Cohort

Florida Cancer Specialists & Research Institute Clinical Expertise And Real-World Evidence Capabilities Advancing Treatment of Blood Cancers

Veeva MedTech adoption boosts clinical trials

Cash Application Coordinator

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. The Cash Application Coordinator is responsible for all cash application functions within the finance department, ensuring accurate cash postings and supporting general operational areas.

Sign up with Google

Sign in with Google